13-24885667-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_018451.5(CPAP):c.3305A>G(p.Asn1102Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000253 in 1,610,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018451.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018451.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CPAP | NM_018451.5 | MANE Select | c.3305A>G | p.Asn1102Ser | missense | Exon 12 of 17 | NP_060921.3 | ||
| CPAP | NR_047594.2 | n.3589A>G | non_coding_transcript_exon | Exon 13 of 18 | |||||
| CPAP | NR_047595.2 | n.3387A>G | non_coding_transcript_exon | Exon 11 of 16 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CENPJ | ENST00000381884.9 | TSL:1 MANE Select | c.3305A>G | p.Asn1102Ser | missense | Exon 12 of 17 | ENSP00000371308.4 | ||
| CENPJ | ENST00000616936.4 | TSL:1 | n.3220A>G | non_coding_transcript_exon | Exon 11 of 16 | ENSP00000477511.1 | |||
| CENPJ | ENST00000471870.1 | TSL:3 | n.195A>G | non_coding_transcript_exon | Exon 3 of 5 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152200Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000155 AC: 39AN: 251336 AF XY: 0.000169 show subpopulations
GnomAD4 exome AF: 0.000254 AC: 370AN: 1458426Hom.: 0 Cov.: 29 AF XY: 0.000254 AC XY: 184AN XY: 725796 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000243 AC: 37AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
In silico analysis supports that this missense variant does not alter protein structure/function; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 1102 of the CENPJ protein (p.Asn1102Ser). This variant is present in population databases (rs41300592, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with CENPJ-related conditions. ClinVar contains an entry for this variant (Variation ID: 21664). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CENPJ protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
CPAP: BP4
Microcephaly 6, primary, autosomal recessive Uncertain:1Other:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Seckel syndrome 4 Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at